HomeAI · summaries
Storia in 2 fonti
Supreme Court backs generic drugmaker in patent case
A unanimous court ruled that a copycat version of a heart drug didn't infringe on the brand-name equivalent's patents.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
axios.com
Supreme Court backs generic drugmaker in patent case
A unanimous court ruled that a copycat version of a heart drug didn't infringe on the brand-name equivalent's patents.
- ·
biopharmadive.com
Generic drugmakers gain key victory in ‘skinny label’ patent case
The Supreme Court ruled that a knockoff version of Amarin’s Vascepa didn’t infringe on patents — a decision with far-reaching implications for the availability of generics.